NDTV

Scientists Develop Blood Test That Predicts The Best Personalised Treatment For Breast Cancer

Breast cancer is one of the most prevalent cancers in the world. The World Health Organization (WHO) says that there were an estimated 2.3 million women diagnosed with breast cancer in 2022. It also ...
ascopubs.org

Plasma Proteome–Based Test for First-Line Treatment Selection in Metastatic Non–Small Cell Lung Cancer

Mutational Analysis of Circulating Tumor DNA in Patients With Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer Receiving Palbociclib: Results From ...
Monthly Prescribing Reference

Waiting for Genomic Test Results to Start Treatment Can Improve OS in NSCLC

Credit: Getty Images. Starting treatment for advanced NSCLC before receiving genomic test results compromises patient outcomes, a study suggests. Starting treatment for advanced non-small cell lung ...
ascopubs.org

Impact of a Genomic Test on Treatment Decision in a Predominantly African American Population With Favorable-Risk Prostate Cancer: A Randomized Trial

Two hundred men with National Comprehensive Cancer Network very low to low-intermediate PCa from three Chicago hospitals (70% Black, 16% college graduates) were randomly assigned at diagnosis to ...